Los Angeles Capital Management & Equity Research Inc. decreased its position in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 71.5% in the third quarter, Holdings Channel reports. The firm owned 185,331 shares of the company’s stock after selling 464,052 shares during the period. Los Angeles Capital Management & Equity Research Inc.’s holdings in Express Scripts were worth $17,608,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Landaas & Co. WI ADV acquired a new stake in Express Scripts during the second quarter valued at $102,000. Kaizen Advisory LLC boosted its position in Express Scripts by 147.6% during the second quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock valued at $104,000 after purchasing an additional 800 shares during the last quarter. Adviser Investments LLC boosted its position in Express Scripts by 321.9% during the second quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock valued at $114,000 after purchasing an additional 1,130 shares during the last quarter. TRUE Private Wealth Advisors acquired a new stake in Express Scripts during the third quarter valued at $115,000. Finally, Sun Life Financial INC boosted its position in Express Scripts by 758.8% during the second quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock valued at $117,000 after purchasing an additional 1,343 shares during the last quarter. 84.20% of the stock is owned by hedge funds and other institutional investors.
Express Scripts stock opened at $98.48 on Friday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.65 and a current ratio of 0.77. The stock has a market capitalization of $56.09 billion, a PE ratio of 11.59, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89. Express Scripts Holding Co has a 52 week low of $59.17 and a 52 week high of $100.43.
Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings data on Wednesday, October 31st. The company reported $2.43 EPS for the quarter, topping analysts’ consensus estimates of $2.42 by $0.01. The business had revenue of $25.56 billion for the quarter, compared to analyst estimates of $25.11 billion. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same period in the previous year, the company posted $2.51 earnings per share. Analysts anticipate that Express Scripts Holding Co will post 9.08 EPS for the current year.
A number of research firms recently issued reports on ESRX. BidaskClub raised Express Scripts from a “hold” rating to a “buy” rating in a research report on Tuesday, September 18th. Royal Bank of Canada lifted their price objective on Express Scripts to $94.00 and gave the company an “outperform” rating in a research report on Monday, August 27th. Robert W. Baird cut Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 price objective for the company. in a research report on Friday, July 20th. Barclays lifted their price objective on Express Scripts from $83.00 to $90.00 and gave the company an “equal weight” rating in a research report on Thursday, November 1st. Finally, William Blair upgraded Express Scripts from a “market perform” rating to an “outperform” rating in a report on Wednesday, August 1st. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Express Scripts currently has an average rating of “Hold” and an average price target of $89.07.
In other news, Director Mahon Thomas P. Mac sold 5,234 shares of Express Scripts stock in a transaction dated Wednesday, November 7th. The stock was sold at an average price of $99.50, for a total value of $520,783.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.79% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/11/10/express-scripts-holding-co-esrx-stake-lowered-by-los-angeles-capital-management-equity-research-inc.html.
Express Scripts Company Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Featured Article: How to Invest in the Dividend Aristocrat Index
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.